Skip to main content
. 2019 Aug 15;11(8):1186. doi: 10.3390/cancers11081186

Table 3.

Changes in serum levels of C3M and C4M between baseline and surgery according to treatment arm.

Changes in Serum Levels C3M n (%) C4M n (%)
Total Trastuzumab Lapatinib Total Trastuzumab Lapatinib
Increase ≥20% 24 (22.6%) 12 (23.1%) 12 (22.2%) 25 (23.6%) 12 (22.6%) 13 (24.5%)
No change 1 43 (40.6%) 20 (38.5%) 23 (42.6%) 58 (54.7%) 29 (54.7%) 29 (54.7%)
Decrease ≥20% 39 (36.8%) 20 (38.5%) 19 (35.2%) 23 (21.7%) 12 (22.6%) 11 (20.8%)

1 defined as an increase <20% or decrease <20%.